CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program) 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR) Application of High-Sensitivity Troponin in Suspected Myocardial Infarction Door to Balloon Time: Is There a Point That Is Too Short? Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Clinical Trial2025 Aug 19;14(16):e041521.

JOURNAL:J Am Heart Assoc. Article Link

Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques

PJ Karhunen, T Pessi, S Hörkkö et al. Keywords: bacteria; biofilm; coronary heart disease; immune system; myocardial infarction.